ReShape Lifesciences Inc. (RSLS) Reports Q2 Net Loss of $7.8M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts RSLS Hot Sheet
Join SI Premium – FREE
ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q2 net loss of $7.8 million. Revenue for the quarter came in at $2.9 million versus the consensus estimate of $3.41 million.
For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- Ternium SA (TX) Misses Q3 EPS by 29c
- Novo Nordisk (NVO) Tops Q3 EPS by 117c; offers outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
